This article explores conditions under which global norms change. I use a case study in which the original interpretation of an international agreement on intellectual property rights was modified to address demands for improved access to affordable AIDS drugs. Conventional theories that focus on international negotiations cannot fully account for the events in this case. Drawing on the theory of recursivity and insights from the literature on diffusion, I suggest that shifts in global norms occur through reactive diffusion of policies across states. Experiences accumulated in this ongoing process of reinvention eventually lead to a new, globally accepted reinterpretation of the original obligation.
AyresB. DrummondJr.. 1999. “Gore Is Followed By AIDS Protesters.” New York Times, July2.
2.
BaldwinDavid A.1993. “Neorealism, Neoliberalism, and World Politics.” Pp. 3–28 in Neorealism and Neoliberalism: The Contemporary Debate, edited by BaldwinD. A.New York: Columbia University Press.
3.
BeckerElizabeth. 2003. “Poor Nations Can Purchase Cheap Drugs Under Accord.” New York Times, August31.
4.
BellmanEric. 2005. “India Senses Patent Appeal.” Wall Street Journal, April11.
5.
BlockRobert. 2001. “South Africa, Drug Firms Near Pact Tied to AIDS.” Wall Street Journal, April18.
6.
BondPatrick. 2003. Against Global Apartheid: South Africa Meets the World Bank, IMF and International Finance. London: Zed Books.
7.
BoseleySarah. 2003. “Chancellor Warns Drug Giants: Sort Out AIDS Row.” The Guardian, February18.
8.
BraithwaiteJohnDrahosPeter. 2000. Global Business Regulation. Cambridge, UK: Cambridge University Press.
9.
Bridges. 2003. “WTO Members Agree on TRIPS and Public Health Text.” 6(July–August):9.
10.
Bridges. 2004. “Zambia to Manufacture Generic HIV/AIDS Medicines.” 8(29), September8.
Bridges. 2006. “Thailand Issues Compulsory License For Patented AIDS Drug.” 10(42), December13.
13.
Bridges. 2007. “Novartis Loses Patent Law Challenge.” 11(5), August.
14.
ChangLeslie. 2002. “China Opens Door to Generic Drugs to Counter AIDS.” Wall Street Journal, September9, p. A12.
15.
DeereCarolyn. 2008. The Implementation Game: The TRIPS Agreement and the Global Politics of Intellectual Property Reform in Developing Countries. London: Oxford University Press.
16.
DezalayYvesGarthBryant G.2002. The Internationalization of Palace Wars. Chicago: University of Chicago Press.
17.
DonnellyJohn. 2001. “Brazil Wins Big Price Cut In Aids Drug Trade-Law.” Boston Globe, September1.
18.
DownieAndrew. 2002. “Brazil Shares AIDS-Fight Blueprint.” Christian Science Monitor, August8.
19.
DrahosPeter. 2002. “Developing Countries and International Intellectual Property Standards-Setting.” Journal of World Intellectual Property5:765–89.
20.
DrahosPeter. 2008. “‘Trust Me’: Patent Offices in Developing Countries.” American Journal of Law & Medicine34:151–74.
21.
FordNathanWilsonDavidBunjumnongOnanongvon Schoen AngererTido. 2004. “The Role of Civil Society in Protecting Public Health Over Commercial Interests: Lessons from Thailand.” The Lancet363:560–63.
22.
FordNathanWilsonDavidChavesGabriela CostaLotrowskaMichelKijtiwatchakulKannikar. 2007. “Sustaining Access to Antiretroviral Therapy in the Less-Developed World: Lessons from Brazil and Thailand.” AIDS21:S21–S29.
23.
FriedmanStevenMottiarShauna. 2005. “A Rewarding Engagement? The Treatment Action Campaign and the Politics of HIV/AIDS.” Politics and Society33:511–65.
24.
GlickHenry R.HaysScott P.1991. “Innovation and Reinvention in State Policymaking: Theory and Evolution of Living Will Laws.” Journal of Politics53:835–50.
25.
GruberLloyd. 2000. Ruling the World: Power Politics and the Rise of Supranational Institutions. Princeton, NJ: Princeton University Press.
26.
HallidayTerence C.CarruthersBruce G.2007. “The Recursivity of Law: Global Norm Making and National Lawmaking in the Globalization of Corporate Insolvency Regimes.” American Journal of Sociology112:1135–1202.
27.
HallidayTerence C.CarruthersBruce G.2009. Bankrupt: Global Lawmaking and Systemic Financial Crisis. Stanford, CA: Stanford University Press.
28.
HaysScott P.1996. “Influences on Reinvention during the Diffusion of Innovations.” Political Research Quarterly49:631–50.
29.
HeniszWitold J.ZelnerBennet A.GuillénMauro F.2005. “The Worldwide Diffusion of Market-Oriented Infrastructure Reform, 1977–1999.” American Sociological Review70:871–97.
30.
HeywoodMark. 2001. “Debunking ‘Conglomo-Talk’: A Case Study of the Amicus Curiae as an Instrument for Advocacy, Investigation and Mobilization.” Law, Democracy and Development5:133–63.
31.
ItanoNicole. 2001. “New Ally in S. Africa’s AIDS Battle.” Christian Science Monitor, May11.
32.
JordanMiriam. 2001a. “Brazil to Break Roche Patent On AIDS Drug.” Wall Street Journal, August23.
33.
JordanMiriam. 2001b. “Brazil Makes a Name for Itself Pumping Out AIDS Drugs.” Wall Street Journal, April27.
34.
KamathGauri. 2001. “India May Follow Brazil Patent Law.” Economic Times, July8.
35.
KlugHeinz. 2005. “Campaigning for Life: Building a New Transnational Solidarity in the Face of HIV/AIDS and TRIPS.” Pp. 118–39 in Law and Globalization from Below, edited by de Sousa SantosB.Rodríguez-Garavito.C. A.New York: Cambridge University Press.
36.
Lancet. 2004. “Comment: Generic Antiretroviral Drugs—Will They Be the Answer to HIV in the Developing World?” The Lancet364:3.
37.
MahoneyJames. 2000. “Path Dependence in Historical Sociology.” Theory and Society29:507–548.
38.
McNeilDonald G.1998. “South Africa’s Bitter Pill for World’s Drug Makers.” New York Times, March29.
39.
McNeilDonald G.2005. “India Alters Law on Drug Patents.” New York Times, March24.
40.
MearsheimerJohn. 1994. “The False Promise of International Institutions.” International Security19:5–49.
41.
Médecins Sans Frontières (MSF). 2001 to 2010. “Untangling the Web of Antiretroviral Price Reductions.” Editions 1 through 13. Campaign for Access to Essential Medicines (http://utw.msfaccess.org/downloads/).
42.
MerkleJudith A.1980. Management and Ideology: The Legacy of the International Scientific Management Movement. Berkeley: University of California Press.
43.
MeyerJohnRowanBrian. 1977. “Institutional Organizations: Formal Structure as Myth and Ceremony.” American Journal of Sociology83:340–63.
44.
MusunguSisuleOhCecilia. 2006. “The Use of Flexibilities in TRIPS by Developing Countries: Can They Promote Access to Medicines?” Geneva, Switzerland: South Centre and the World Health Organization.
NelsonKathleen.2003. “GSK and Boehringer Agree to Generic AIDS Drugs Deal.” The Lancet362:2074.
47.
Oxfam. 2001. “The Impact of Patent Rules on the Treatment of HIV/AIDS in Thailand.” Oxfam GB, March.
48.
PetersenMelody. 2001. “Lifting the Curtain on the Real Costs of Making AIDS Drugs.” New York Times, April24.
49.
PrasadGireesh Chandra. 2007. “Copycats Popping Patent Law Pill.” The Economic Times, India, August3.
50.
PrasadMonica. 2006. The Politics of Free Markets: The Rise of Neoliberal Economic Policies in Britain, France, Germany, and the United States. Chicago: University of Chicago Press.
51.
President’s Emergency Plan for AIDS Relief (PEPFAR). 2008. “Report to Congress by the U.S. Global AIDS Coordinator on the Use of Generic Drugs in the President’s Emergency Plan for AIDS Relief.” PEPFAR: Washington, DC.
52.
PutnamRobert D.1988. “Diplomacy and Domestic Politics: The Logic of Two-Level Games.” International Organization42:427–60.
53.
Reuters. 2008. “Brazil Rejects Gilead’s AIDS Drug Patent.” September3.
54.
RobertsonDavid B.WaltmanJerold L.1993. “The Politics of Policy Borrowing.” Pp. 21–45 in Something Borrowed, Something Learned, edited by FinegoldD.McFarlandL.Richardson.W.Washington, DC: Brookings Institution.
55.
RogersEverett. 1983. Diffusion of Innovations, 3rd ed.New York: Free Press.
56.
RossiFrancisco. 2006. “Free Trade Agreements and TRIPS-Plus Measures.” International Journal of Intellectual Property Management1:150–72.
57.
SchwartländerBernhardGrubbIanPerriënsJos. 2006. “The 10-Year Struggle to Provide Antiretroviral Treatment to People with HIV in the Developing World.” The Lancet368:541–46.
58.
SellSusan K.2003. Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge, UK: Cambridge University Press.
59.
SellSusan K.2007. “TRIPS-Plus Free Trade Agreements and Access to Medicines.” Liverpool Law Review28:41–75.
60.
SellSusan K.PrakashAseem. 2004. “Using Ideas Strategically: The Contest between Business and NGO Networks in Intellectual Property Rights.” International Studies Quarterly48:143–75.
61.
ShadlenKenneth C.2004. “Patents and Pills, Power and Procedure: The North-South Politics of Public Health in the WTO.” Studies in Comparative International Development39:76–108.
62.
ShadlenKenneth C.2009. “The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies.” Comparative Politics42:41–58.
63.
ShadlenKenneth C.Forthcoming “The Politics of Pharmaceutical Patent Examination in Brazil.” In Knowledge Governance, Development and Democracy, edited by BurlamaquiL.Celia CastroA.KattelR.London: Anthem Press.
64.
SimmonsBeth A.DobbinFrankGarrettGeoffrey. 2006. “The Diffusion of Liberalism.” International Organization60:781–810.
65.
SouzaAndre de Mello e. 2007. “Defying Globalization: Effective Self-Reliance in Brazil.” Pp. 37–64 in The Global Politics of AIDS, edited by HarrisP. G.SiplonP. D.Boulder, CO: Lynne Rienner Publishers.
66.
SpecterMichael. 2001. “Annals of Medicine: India’s Plague.” The New Yorker, December17, pp. 74–85.
67.
StrangDavid. 2010. Learning by Example: Imitation and Innovation at a Global Bank. Princeton, NJ: Princeton University Press.
68.
SubramanianNithya. 2005. “Foreign Nations Lobbying PMO for Favourable Patents Law.” The Hindu Business Line, March11.
69.
Times of India. 2005. “‘What Happened to Condom Promises?’” March12.
70.
UNAIDS. 2006. “Report on the Global AIDS Epidemic 2006.” Geneva: UNAIDS.
71.
UNAIDS. 2008. “Report on the Global AIDS Epidemic 2008.” Geneva: UNAIDS.
72.
Wall Street Journal. 2007. “Theft in Thailand.” February10.
73.
WaltGillLushLouisianaOgdenJessica. 2004. “International Organizations in Transfer of Infectious Diseases: Iterative Loops of Adoption, Adaptation, and Marketing.” Governance17:189–210.
74.
WejnertBarbara. 2002. “Integrating Models of Diffusion of Innovations: A Conceptual Framework.” Annual Review of Sociology28:297–326.
75.
WeylandKurt. 2005. “Theories of Policy Diffusion: Lessons from Latin American Pension Reform.” World Politics57:262–95.
76.
WilsonDavidCawthornePaulFordNathanAongsonwangSaree. 1999. “Global Trade and Access to Medicines: AIDS Treatments in Thailand.” The Lancet354:1893–95.
77.
WiseJacqui. 2006. “Access to AIDS Medicines Stumbles on Trade Rules.” Bulletin of the World Health Organization84:342–44.
78.
World Health Organization (WHO). 1997. “Globalization and Access to Drugs: Implications of the WTO/TRIPS Agreement.” Geneva, Switzerland: WHO Press.
79.
World Health Organization (WHO). 2010. “Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2010.” Geneva, Switzerland: WHO Press.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
